FONDAZIONE BIOTECNOPOLO DI SIENA
Non-profit foundation based in Siena focused on applied research, innovation and technology transfer in biotechnology and life sciences. Acts as a national pandemic-preparedness hub coordinating sequencing networks and centres for research, development and production of vaccines and monoclonal antibodies, and supports multidisciplinary training and partnerships.
Industries
N/A
Nr. of Employees
medium (51-250)
FONDAZIONE BIOTECNOPOLO DI SIENA
Services
Coordination of a central hub with spoke centres and integration of national sequencing networks to support preparedness and response.
Research and development support for vaccine candidates and monoclonal antibodies, including collaboration in pan‑European initiatives.
Support for pathogen sequencing for surveillance and research purposes across a networked infrastructure.
Co‑funding and participation in multidisciplinary doctoral training in diagnostics, prevention and therapy of epidemic‑risk infections.
Coordination of a central hub with spoke centres and integration of national sequencing networks to support preparedness and response.
Research and development support for vaccine candidates and monoclonal antibodies, including collaboration in pan‑European initiatives.
Support for pathogen sequencing for surveillance and research purposes across a networked infrastructure.
Co‑funding and participation in multidisciplinary doctoral training in diagnostics, prevention and therapy of epidemic‑risk infections.
Expertise Areas
- Pandemic preparedness and response
- Vaccine research and development
- Monoclonal antibody development
- Genomic surveillance and pathogen sequencing
Key Technologies
- Next‑generation pathogen sequencing
- Vaccine platform technologies
- Monoclonal antibody discovery and production methods
- Serology and immunoassay platforms
News & Updates
Announcement of a national doctoral program in innovation for diagnosis, prevention and therapy of infections at epidemic‑pandemic risk, coordinated by the University of Siena and co‑funded by the foundation.
Article about a three‑year collaboration agreement with a paediatric hospital to address viruses and antibiotic resistance.
Interview on the strategic role of preparedness and response in Europe and perspectives on European coordination for health emergency readiness.
Announcement of participation in a pan‑European vaccines hub for pandemic readiness co‑financed by a European authority.
Notice of an award to the foundation's Head of Serology and Immunology for contributions to understanding and treating zoonotic viral infections such as SARS‑CoV‑2.
Announcement of an international award to the foundation's scientific director, recognising contributions to infectious diseases research.
Announcement of a national doctoral program in innovation for diagnosis, prevention and therapy of infections at epidemic‑pandemic risk, coordinated by the University of Siena and co‑funded by the foundation.
Article about a three‑year collaboration agreement with a paediatric hospital to address viruses and antibiotic resistance.
Interview on the strategic role of preparedness and response in Europe and perspectives on European coordination for health emergency readiness.
Announcement of participation in a pan‑European vaccines hub for pandemic readiness co‑financed by a European authority.
Notice of an award to the foundation's Head of Serology and Immunology for contributions to understanding and treating zoonotic viral infections such as SARS‑CoV‑2.
Announcement of an international award to the foundation's scientific director, recognising contributions to infectious diseases research.